PD Dr. med. Philipp Kohler
Leitende(r) Arzt/Ärztin
Infektiologie | Spitalhygiene · Dept. I
Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study).
Kohler P, Babouee Flury B, Güsewell S, Egger T, Leal-Neto O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Ortner M, Rieder P, Ruetti M, Schmid H, Stocker R, Vuichard-Gysin D, Speer O, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kahlert C, Kuster S, SURPRISE Study Group. Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study). Influenza Other Respir Viruses 2023; 17:e13167.
19.06.2023Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study).
19.06.2023Influenza Other Respir Viruses 2023; 17:e13167
Kohler Philipp, Babouee Flury Baharak, Güsewell Sabine, Egger Thomas, Leal-Neto Onicio B, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J. Carsten, Ortner Manuela, Rieder Philippe, Ruetti Markus, Schmid Hans Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Speer Oliver, Wiggli Benedikt, Besold Ulrike, McGeer Allison J, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro L, Kahlert Christian, Kuster Stefan, SURPRISE Study Group
Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.
Sumer J, Keckeis K, Scanferla G, Frischknecht M, Notter J, Steffen A, Kohler P, Schmid P, Roth B, Wissel K, Vernazza P, Klein P, Schoop R, Albrich W. Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial. Front Med (Lausanne) 2023; 10:948787.
17.04.2023Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.
17.04.2023Front Med (Lausanne) 2023; 10:948787
Sumer Johannes, Keckeis Karin, Scanferla Giulia, Frischknecht Manuel, Notter Julia, Steffen Ana, Kohler Philipp, Schmid Patrick, Roth Bianca, Wissel Kerstin, Vernazza Pietro L, Klein Peter, Schoop Roland, Albrich Werner
COVID-19 burden and influencing factors in Swiss long-term-care facilities: a cross-sectional analysis of a multicentre observational cohort.
Scanferla G, Héquet D, Graf N, Münzer T, Kessler S, Kohler P, Nussbaumer A, Petignat C, Schlegel M, Flury D. COVID-19 burden and influencing factors in Swiss long-term-care facilities: a cross-sectional analysis of a multicentre observational cohort. Swiss Med Wkly 2023; 153:40052.
31.03.2023COVID-19 burden and influencing factors in Swiss long-term-care facilities: a cross-sectional analysis of a multicentre observational cohort.
31.03.2023Swiss Med Wkly 2023; 153:40052
Scanferla Giulia, Héquet Delphine, Graf Nicole, Münzer Thomas, Kessler Simone, Kohler Philipp, Nussbaumer Andres, Petignat Christiane, Schlegel Matthias, Flury Domenica
Impact of the coronavirus disease 2019 (COVID-19) pandemic on the adherence to hand hygiene practice in hospitals-Data from a Swiss national surveillance system.
Rüfenacht S, Kohler P, Kuhn R, Flury D, Widmer A, Schlegel M. Impact of the coronavirus disease 2019 (COVID-19) pandemic on the adherence to hand hygiene practice in hospitals-Data from a Swiss national surveillance system. Infect Control Hosp Epidemiol 2023:1-4.
10.01.2023Impact of the coronavirus disease 2019 (COVID-19) pandemic on the adherence to hand hygiene practice in hospitals-Data from a Swiss national surveillance system.
10.01.2023Infect Control Hosp Epidemiol 2023:1-4
Rüfenacht Susanne, Kohler Philipp, Kuhn Rolf, Flury Domenica, Widmer Andreas F, Schlegel Matthias
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Sinnberg T, Lichtensteiger C, Ali O, Pop O, Risch L, Brugger S, Velic A, Bomze D, Kohler P, Vernazza P, Albrich W, Kahlert C, Abdou M, Wyss N, Hofmeister K, Niessner H, Zinner C, Gilardi M, Tzankov A, Röcken M, Dulovic A, Shambat S, Ruetalo N, Buehler P, Scheier T, Jochum W, Kern L, Henz S, Schneider T, Kuster G, Lampart M, Siegemund M, Bingisser R, Schindler M, Schneiderhan-Marra N, Kalbacher H, McCoy K, Spengler W, Brutsche M, Macek B, Twerenbold R, Penninger J, Matter M, Flatz L, Jochum A. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19. Am J Respir Crit Care Med 2023; 207:38-49.
01.01.2023Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
01.01.2023Am J Respir Crit Care Med 2023; 207:38-49
Sinnberg Tobias, Lichtensteiger Christa, Ali Omar Hasan, Pop Oltin T, Risch Lorenz, Brugger Silvio D, Velic Ana, Bomze David, Kohler Philipp, Vernazza Pietro, Albrich Werner C, Kahlert Christian R, Abdou Marie-Therese, Wyss Nina, Hofmeister Kathrin, Niessner Heike, Zinner Carl, Gilardi Mara, Tzankov Alexandar, Röcken Martin, Dulovic Alex, Shambat Srikanth Mairpady, Ruetalo Natalia, Buehler Philipp K, Scheier Thomas C, Jochum Wolfram, Kern Lukas, Henz Samuel, Schneider Tino, Kuster Gabriela M, Lampart Maurin, Siegemund Martin, Bingisser Roland, Schindler Michael, Schneiderhan-Marra Nicole, Kalbacher Hubert, McCoy Kathy D, Spengler Werner, Brutsche Martin H, Macek Boris, Twerenbold Raphael, Penninger Josef M, Matter Matthias S, Flatz Lukas, Jochum Ann-Kristin
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B, Güsewell S, Egger T, Leal O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Rieder P, Rütti M, Schmid H, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Kuster S, Kahlert C, Kohler P, SURPRISE Study Group. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study. PLoS Med 2022; 19:e1004125.
07.11.2022Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
07.11.2022PLoS Med 2022; 19:e1004125
Babouee Flury Baharak, Güsewell Sabine, Egger Thomas, Leal Onicio, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J Carsten, Rieder Philip, Rütti Markus, Schmid Hans-Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Wiggli Benedikt, Besold Ulrike, McGeer Allison, Risch Lorenz, Friedl Andree, Schlegel Matthias, Kuster Stefan P, Kahlert Christian R, Kohler Philipp, SURPRISE Study Group
Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort.
Strahm C, Seneghini M, Güsewell S, Egger T, Leal-Neto O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Rieder P, Ruetti M, Rutz R, Schmid H, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, Kuster S, McGeer A, Risch L, Friedl A, Schlegel M, Schmid D, Vernazza P, Kahlert C, Kohler P. Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort. Clin Infect Dis 2022; 75:e1011-e1019-9.
24.08.2022Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort.
24.08.2022Clin Infect Dis 2022; 75:e1011-e1019-9
Strahm Carol, Seneghini Marco, Güsewell Sabine, Egger Thomas, Leal-Neto Onicio, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J Carsten, Rieder Philip, Ruetti Markus, Rutz Remus, Schmid Hans Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Wiggli Benedikt, Besold Ulrike, Kuster Stefan P, McGeer Allison, Risch Lorenz, Friedl Andree, Schlegel Matthias, Schmid Dagmar, Vernazza Pietro, Kahlert Christian R, Kohler Philipp
Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type.
Dörr T, Haller S, Müller M, Friedl A, Vuichard D, Kahlert C, Kohler P. Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type. JAMA Netw Open 2022; 5:e2226816.
01.08.2022Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type.
01.08.2022JAMA Netw Open 2022; 5:e2226816
Dörr Tamara, Haller Sabine, Müller Maja F, Friedl Andree, Vuichard Danielle, Kahlert Christian R, Kohler Philipp
Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas.
Blankenberger J, Kriemler S, Michel G, Rodondi N, Rodondi P, Speierer A, Tancredi S, Puhan M, Kahlert C, Kohler P, Harju E, Fehr J, Kaufmann M, Albanese E, Amati R, Anker D, Camerini A, Chocano-Bedoya P, Cullati S, Cusini A, Corona Immunitas Research Group. Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas. BMC Med 2022; 20:233.
20.06.2022Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas.
20.06.2022BMC Med 2022; 20:233
Blankenberger Jacob, Kriemler Susi, Michel Gisela, Rodondi Nicolas, Rodondi Pierre-Yves, Speierer Alexandre, Tancredi Stefano, Puhan Milo A, Kahlert Christian R, Kohler Philipp, Harju Erika, Fehr Jan, Kaufmann Marco, Albanese Emiliano, Amati Rebecca, Anker Daniela, Camerini Anne-Linda, Chocano-Bedoya Patricia O, Cullati Stéphane, Cusini Alexia, Corona Immunitas Research Group
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.
Rüfenacht S, Gantenbein P, Boggian K, Flury D, Kern L, Dollenmaier G, Kohler P, Albrich W. Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series. Infection 2022; 50:783-790.
15.04.2022Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.
15.04.2022Infection 2022; 50:783-790
Rüfenacht Susanne, Gantenbein Pascal, Boggian Katia, Flury Domenica, Kern Lukas, Dollenmaier Günter, Kohler Philipp, Albrich Werner C
It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance—An expert review
Seneghini M, Rüfenacht S, Babouee Flury B, Flury D, Schlegel M, Kuster S, Kohler P. It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance—An expert review. Antimicrobial Stewardship & Healthcare Epidemiology 2022
23.02.2022It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance—An expert review
23.02.2022Antimicrobial Stewardship & Healthcare Epidemiology 2022
Seneghini Marco, Rüfenacht Susanne, Babouee Flury Baharak, Flury Domenica, Schlegel Matthias, Kuster Stefan, Kohler Philipp
It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance-An expert review.
Seneghini M, Rüfenacht S, Babouee Flury B, Flury D, Schlegel M, Kuster S, Kohler P. It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance-An expert review. Antimicrob Steward Healthc Epidemiol 2022; 2:e27.
18.02.2022It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance-An expert review.
18.02.2022Antimicrob Steward Healthc Epidemiol 2022; 2:e27
Seneghini Marco, Rüfenacht Susanne, Babouee Flury Baharak, Flury Domenica, Schlegel Matthias, Kuster Stefan, Kohler Philipp
Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic-A Prospective Cohort
Sumer J, Schlegel M, Vernazza P, Seneghini M, Nigg S, Risch L, Mueller N, Kahlert C, Flury D, Kohler P. Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic-A Prospective Cohort. Int J Public Health 2022; 67:1604147.
16.02.2022Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic-A Prospective Cohort
16.02.2022Int J Public Health 2022; 67:1604147
Sumer Johannes, Schlegel Matthias, Vernazza Pietro, Seneghini Marco, Nigg Susanne, Risch Lorenz, Mueller Nicolas J, Kahlert Christian, Flury Domenica, Kohler Philipp
Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort
Haller S, Vuichard-Gysin D, Wiggli B, Besold U, Kuster S, McGeer A, Risch L, Schlegel M, Friedl A, Vernazza P, Kahlert C, Stocker R, Rütti M, Güsewell S, Egger T, Scanferla G, Thoma R, Leal-Neto O, Flury D, Brucher A, Lemmenmeier E, Möller J, Rieder P, Kohler P. Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort. Antimicrob Resist Infect Control 2022; 11:27.
05.02.2022Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort
05.02.2022Antimicrob Resist Infect Control 2022; 11:27
Haller Sabine, Vuichard-Gysin Danielle, Wiggli Benedikt, Besold Ulrike, Kuster Stefan, McGeer Allison, Risch Lorenz, Schlegel Matthias, Friedl Andree, Vernazza Pietro, Kahlert Christian, Stocker Reto, Rütti Markus, Güsewell Sabine, Egger Thomas, Scanferla Giulia, Thoma Reto, Leal-Neto Onicio B, Flury Domenica, Brucher Angela, Lemmenmeier Eva, Möller J Carsten, Rieder Philip, Kohler Philipp
The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature.
Thoma R, Seneghini M, Seiffert S, Vuichard Gysin D, Scanferla G, Haller S, Flury D, Boggian K, Kleger G, Filipovic M, Nolte O, Schlegel M, Kohler P. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature. Antimicrob Resist Infect Control 2022; 11:12.
21.01.2022The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature.
21.01.2022Antimicrob Resist Infect Control 2022; 11:12
Thoma Reto, Seneghini Marco, Seiffert Salome N, Vuichard Gysin Danielle, Scanferla Giulia, Haller Sabine, Flury Domenica, Boggian Katia, Kleger Gian-Reto, Filipovic Miodrag, Nolte Oliver, Schlegel Matthias, Kohler Philipp
No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
Kohler P, Jonsdottir H, Risch L, Vernazza P, Ackermann-Gäumann R, Kahlert C. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study. Sci Rep 2021; 11:24198.
17.12.2021No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
17.12.2021Sci Rep 2021; 11:24198
Kohler Philipp, Jonsdottir Hulda R, Risch Lorenz, Vernazza Pietro, Ackermann-Gäumann Rahel, Kahlert Christian
Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
Leal-Neto O, Kahlert C, Vernazza P, Kuster S, Babouee Flury B, Albrich W, Sumer J, Flury D, Schlegel M, Egger T, Kohler P. Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study. JMIR Public Health Surveill 2021; 7:e33576.
22.11.2021Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
22.11.2021JMIR Public Health Surveill 2021; 7:e33576
Leal-Neto Onicio, Kahlert Christian, Vernazza Pietro, Kuster Stefan, Babouee Flury Baharak, Albrich Werner, Sumer Johannes, Flury Domenica, Schlegel Matthias, Egger Thomas, Kohler Philipp
Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Hasan Ali O, Bomze D, Risch L, Brugger S, Paprotny M, Weber M, Thiel S, Kern L, Albrich W, Kohler P, Kahlert C, Vernazza P, Bühler P, Schüpbach R, Gómez-Mejia A, Popa A, Bergthaler A, Penninger J, Flatz L. Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:1746.
02.11.2021Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
02.11.2021Clin Infect Dis 2021; 73:1746
Hasan Ali Omar, Bomze David, Risch Lorenz, Brugger Silvio D, Paprotny Matthias, Weber Myriam, Thiel Sarah, Kern Lukas, Albrich Werner C, Kohler Philipp, Kahlert Christian R, Vernazza Pietro, Bühler Philipp K, Schüpbach Reto A, Gómez-Mejia Alejandro, Popa Alexandra M, Bergthaler Andreas, Penninger Josef M, Flatz Lukas
Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018
Barnsteiner S, Kohler P, Kronenberg A, Schlegel M, Plüss-Suard C, Gasser M, Babouee Flury B, Albrich W, Baty F, Swiss Centre for Antibiotic Resistance (ANRESIS). Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Euro Surveill 2021; 26
01.11.2021Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018
01.11.2021Euro Surveill 2021; 26
Barnsteiner Stefanie, Kohler Philipp, Kronenberg Andreas, Schlegel Matthias, Plüss-Suard Catherine, Gasser Michael, Babouee Flury Baharak, Albrich Werner C, Baty Florent, Swiss Centre for Antibiotic Resistance (ANRESIS)
Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study
Kohler P, Wiggli B, Besold U, Kuster S, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Vuichard-Gysin D, Stocker R, Ruetti M, Güsewell S, Seneghini M, Egger T, Leal O, Brucher A, Lemmenmeier E, Möller J, Rieder P, Kahlert C. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study. BMC Med 2021; 19:270.
14.10.2021Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study
14.10.2021BMC Med 2021; 19:270
Kohler Philipp, Wiggli Benedikt, Besold Ulrike, Kuster Stefan, McGeer Allison, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro, Vuichard-Gysin Danielle, Stocker Reto, Ruetti Markus, Güsewell Sabine, Seneghini Marco, Egger Thomas, Leal Onicio, Brucher Angela, Lemmenmeier Eva, Möller J Carsten, Rieder Philip, Kahlert Christian